---
title: Targeting Caseinolytic Mitochondrial Matrix Peptidase, a Novel Contributor
  to High-risk Behavior, in Multiple Myeloma
date: '2025-02-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39912779/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250207170829&v=2.18.0.post9+e462414
source: Blood
description: Plasma cell dyscrasias encompass a spectrum from the precursors monoclonal
  gammopathy of undetermined significance and smoldering myeloma to symptomatic myeloma,
  but the genes that enable progression and confer poor prognosis are incompletely
  understood. Using single cell transcriptomics, we identified the Caseinolytic protease
  proteolytic subunit (CLPP), a key component of the mitochondrial CLP serine endopeptidase,
  as being over-expressed in CD138+ neoplastic versus normal, and in ...
disable_comments: true
---
Plasma cell dyscrasias encompass a spectrum from the precursors monoclonal gammopathy of undetermined significance and smoldering myeloma to symptomatic myeloma, but the genes that enable progression and confer poor prognosis are incompletely understood. Using single cell transcriptomics, we identified the Caseinolytic protease proteolytic subunit (CLPP), a key component of the mitochondrial CLP serine endopeptidase, as being over-expressed in CD138+ neoplastic versus normal, and in ...